Terms: = Thyroid cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG
166 results:
1. Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy.
Takahara Y; Abe R; Sumito N; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T
Thorac Cancer; 2024 Apr; 15(12):987-993. PubMed ID: 38485287
[TBL] [Abstract] [Full Text] [Related]
2. Suprasellar masquerader: Chordoid glioma.
Bhardwaj N; Salunke P; Singla N; Ahuja C; Gendle C; Gupta K
Clin Neuropathol; 2024; 43(1):23-28. PubMed ID: 37675487
[TBL] [Abstract] [Full Text] [Related]
3. Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations.
Sejben A; Pancsa T; Tiszlavicz L; Furák J; Paróczai D; Zombori T
Thorac Cancer; 2023 Apr; 14(10):857-863. PubMed ID: 36808895
[TBL] [Abstract] [Full Text] [Related]
4. Expression landscapes in non-small cell lung cancer shaped by the thyroid transcription factor 1.
Gloriane C Luna H; Severino Imasa M; Juat N; Hernandez KV; May Sayo T; Cristal-Luna G; Marie Asur-Galang S; Bellengan M; John Duga K; Brian Buenaobra B; De Los Santos MI; Medina D; Samo J; Minerva Literal V; Andrew Bascos N; Sy-Naval S
Lung Cancer; 2023 Feb; 176():121-131. PubMed ID: 36634573
[TBL] [Abstract] [Full Text] [Related]
5. Current picture of anaplastic thyroid cancer patients' care and meetable needs: A survey of 94 Institutions from the EORTC Endocrine and Head and Neck cancer Groups.
Locati LD; Colombo E; Dedecjus M; de la Fouchardière C; Sents W; Bongiovanni M; Netea-Maier R
Eur J Cancer; 2023 Feb; 180():146-154. PubMed ID: 36599182
[TBL] [Abstract] [Full Text] [Related]
6. Delayed-onset immune-related adverse events involving the thyroid gland by immune checkpoint inhibitors in combination with chemotherapy: a case report and retrospective cohort study.
Ueba Y; Yamauchi I; Hakata T; Fujita H; Okamoto K; Ikeda K; Ueda Y; Fujii T; Taura D; Inagaki N
Endocr J; 2023 Mar; 70(3):323-332. PubMed ID: 36464271
[TBL] [Abstract] [Full Text] [Related]
7. Multi-Targeting Nano-Systems Targeting Heterogeneous cancer Cells for Therapeutics and Biomarker Detection.
Ren XH; Han D; He XY; Guo T; Chen XS; Pang X; Cheng SX
Adv Healthc Mater; 2023 Feb; 12(4):e2202155. PubMed ID: 36333906
[TBL] [Abstract] [Full Text] [Related]
8. Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability.
Hong S; Xie Y; Cheng Z; Li J; He W; Guo Z; Zhang Q; Peng S; He M; Yu S; Xu L; Liu R; Xu T; Zhang Y; Li Y; Wang J; Lv W; Yu J; Xiao H
Oncogene; 2022 Nov; 41(47):5121-5132. PubMed ID: 36253446
[TBL] [Abstract] [Full Text] [Related]
9. Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic cancer.
Yokoyama S; Iwaya H; Akahane T; Hamada T; Higashi M; Hashimoto S; Tanoue S; Ohtsuka T; Ido A; Tanimoto A
Diagn Cytopathol; 2022 Nov; 50(11):499-507. PubMed ID: 36181430
[TBL] [Abstract] [Full Text] [Related]
10. Amphicrine Medullary thyroid Carcinoma - a Case-Based Review Expanding on Its MUC Expression Profile.
Khandakar H; Agarwal S; Sharma MC; Kandasamy D; Bal C; Rathode Y; Aphale R
Endocr Pathol; 2022 Sep; 33(3):378-387. PubMed ID: 35733030
[TBL] [Abstract] [Full Text] [Related]
11. Primary Malignant Peripheral Nerve Sheath Tumor of the Stomach: A Rare Case Report and Review of Literature.
Cui W; Xing L; Fu L; Shi L; Li X
Int J Surg Pathol; 2023 Apr; 31(2):221-226. PubMed ID: 35491655
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological observation of mature teratoma with malignant transformation, a single center retrospective study.
Yuan Y; Li H; Yang H
Indian J Pathol Microbiol; 2022; 65(2):369-373. PubMed ID: 35435373
[TBL] [Abstract] [Full Text] [Related]
13. A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring.
Zanchetta M; Iacuzzi V; Posocco B; Bortolin G; Poetto AS; Orleni M; Canil G; Guardascione M; Foltran L; Fanotto V; Puglisi F; Gagno S; Toffoli G
PLoS One; 2021; 16(10):e0259137. PubMed ID: 34699578
[TBL] [Abstract] [Full Text] [Related]
14. FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated thyroid cancer: Evaluation of the Preclinical Rationale.
Adam P; Kircher S; Sbiera I; Koehler VF; Berg E; Knösel T; Sandner B; Fenske WK; Bläker H; Smaxwil C; Zielke A; Sipos B; Allelein S; Schott M; Dierks C; Spitzweg C; Fassnacht M; Kroiss M
Front Endocrinol (Lausanne); 2021; 12():712107. PubMed ID: 34475850
[TBL] [Abstract] [Full Text] [Related]
15. Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
Ditsch N; Heublein S; Jeschke U; Sattler C; Kuhn C; Hester A; Czogalla B; Trillsch F; Mahner S; Engel J; Mayr D; Schmoeckel E
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1923-1932. PubMed ID: 32533406
[TBL] [Abstract] [Full Text] [Related]
16. Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors.
Sandblom V; Spetz J; Shubbar E; Montelius M; Ståhl I; Swanpalmer J; Nilsson O; Forssell-Aronsson E
PLoS One; 2020; 15(5):e0233720. PubMed ID: 32459817
[TBL] [Abstract] [Full Text] [Related]
17. Predicted Prognosis of Patients with Pancreatic cancer by Machine Learning.
Yokoyama S; Hamada T; Higashi M; Matsuo K; Maemura K; Kurahara H; Horinouchi M; Hiraki T; Sugimoto T; Akahane T; Yonezawa S; Kornmann M; Batra SK; Hollingsworth MA; Tanimoto A
Clin Cancer Res; 2020 May; 26(10):2411-2421. PubMed ID: 31992588
[TBL] [Abstract] [Full Text] [Related]
18. Ovarian metastases reported after adjuvant laparoscopic oophorectomies in breast cancer.
Cristian DA; Grama FA; Becheanu G; Popa I; Bratu AM; Burcoş T; Poalelungi CV; Şurlin V
Rom J Morphol Embryol; 2019; 60(3):913-920. PubMed ID: 31912104
[TBL] [Abstract] [Full Text] [Related]
19. Mucinous lung adenocarcinoma, particularly referring to EGFR-mutated mucinous adenocarcinoma.
Wakejima R; Inamura K; Ninomiya H; Nagano H; Mun M; Okumura S; Okubo K; Ishikawa Y
Pathol Int; 2020 Feb; 70(2):72-83. PubMed ID: 31859434
[TBL] [Abstract] [Full Text] [Related]
20. Kinetic Analysis of Growth Activity in Enlarging Papillary thyroid Microcarcinomas.
Ito Y; Miyauchi A; Kudo T; Higashiyama T; Masuoka H; Kihara M; Miya A
Thyroid; 2019 Dec; 29(12):1765-1773. PubMed ID: 31650907
[No Abstract] [Full Text] [Related]
[Next]
